Association of asthma with myasthenia gravis presents a twofold peculiarity. First, as dyspnea characterizes both conditions, diagnostic orientation is difficult. Second, from a therapeutic standpoint, the initiation of anticholinesterase treatment requires a multidisciplinary approach due to possible contraindication for asthma. We report on the case of a patient monitored for severe asthma and treated with biotherapy, and also monitored for myasthenia gravis, and treated with anticholinesterase.
Keywords: Anticholinergic; Anticholinergique; Anticholinesterase; Anticholinestérasique; Asthme sévère; Severe asthma.
Copyright © 2021 SPLF. Published by Elsevier Masson SAS. All rights reserved.